CC
Chicago Capital Management, LLC
13F filer · CIK 0001580162Reported Jul 22, 2026
13F portfolio value$112MU.S. long equity reported on 13F
Positions12Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight42.6%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 22, 202612 positions | |||||
| NNUVLNuvalent, Inc. | $11.1M | 9.84% | 3.69% | New | Q2 2026 |
| ATAPGEApogee Therapeutics, Inc. | $9.81M | 8.73% | 0.13% | New | Q2 2026 |
| CIGTLSChart Industries Inc | $8.36M | 7.44% | 0.11% | Not reported | Q1 2026 |
| TMTMHCTaylor Morrison Home Corp | $7.17M | 6.39% | 0.14% | New | Q2 2026 |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $2.93M | 2.61% | 0.10% | New | Q2 2026 |
| AALOTAstroNova, Inc. | $2.85M | 2.54% | 1.69% | New | Q2 2026 |
| ETESPREsperion Therapeutics, Inc. | $2.61M | 2.32% | 0.32% | New | Q2 2026 |
| $2.02M | 1.80% | 0.02% | New | Q2 2026 | |
| CPTBRGComputer Programs & Systems Inc | $686K | 0.61% | Not reported | New | Q2 2026 |
| EAEAElectronic Arts Inc. | $309K | 0.28% | Not reported | Not reported | Q4 2025 |
| $304K | 0.27% | 0.55% | New | Q2 2026 | |
| $26.4K | 0.02% | Not reported | New | Q2 2026 | |
| Q1 2026Reported Apr 27, 202611 positions | |||||
| CIGTLSChart Industries Inc | $8.27M | 6.85% | 0.11% | New | Q1 2026 |
| AACLXArcellx, Inc. | $8.04M | 6.66% | 0.16% | New | Q1 2026 |
| ATFOLDAmicus Therapeutics, Inc. | $7.23M | 5.99% | 0.21% | +66.5% | Q4 2025 |
| APAPLSApellis Pharmaceuticals, Inc. | $5.76M | 4.77% | 0.15% | New | Q1 2026 |
| TPTERNTerns Pharmaceuticals, Inc. | $5.14M | 4.26% | 0.11% | New | Q1 2026 |
| DHDHILDiamond Hill Investment Group Inc | $1.46M | 1.21% | 0.42% | New | Q1 2026 |
| BFBLFYBlue Foundry Bancorp | $1.45M | 1.20% | 0.76% | +639.9% | Q4 2025 |
| THTHRThermon Group Holdings, Inc. | $1.14M | 0.95% | 0.09% | New | Q1 2026 |
| EAEAElectronic Arts Inc. | $307K | 0.25% | Not reported | Not reported | Q4 2025 |
| DODAWNDay One Biopharmaceuticals, Inc. | $162K | 0.13% | 0.01% | New | Q1 2026 |
| HCHTBKHeritage Commerce Corp | $132K | 0.11% | 0.02% | New | Q1 2026 |
| Q4 2025Reported Feb 2, 202617 positions | |||||
| CTCDTXCidara Therapeutics, Inc. | $8.17M | 5.56% | 0.16% | New | Q4 2025 |
| $6.56M | 4.47% | 0.03% | New | Q4 2025 | |
| CCFLTConfluent, Inc. | $5.34M | 3.63% | 0.22% | New | Q4 2025 |
| ATATXSAstria Therapeutics, Inc. | $5.24M | 3.56% | 0.93% | New | Q4 2025 |
| HHOLXHologic Inc | $4.78M | 3.25% | 0.04% | New | Q4 2025 |
| ATFOLDAmicus Therapeutics, Inc. | $4.28M | 2.92% | 0.13% | New | Q4 2025 |
| ABRNAMAvidity Biosciences, Inc. | $1.91M | 1.30% | 0.02% | New | Q4 2025 |
| DDAYDayforce, Inc. | $1.8M | 1.22% | 0.02% | New | Q4 2025 |
| $1.39M | 0.95% | Not reported | New | Q4 2025 | |
| STSNCRSynchronoss Technologies, Inc | $1.17M | 0.80% | 1.59% | New | Q4 2025 |
| IBIROQIF Bancorp, Inc. | $1.02M | 0.69% | 1.14% | New | Q4 2025 |
| $407K | 0.28% | 0.16% | New | Q4 2025 | |
| GIGIFIGulf Island Fabrication Inc | $333K | 0.23% | 0.23% | New | Q4 2025 |
| FSFSFGFirst Savings Financial Group, Inc. | $312K | 0.21% | 0.19% | New | Q4 2025 |
| EAEAElectronic Arts Inc. | $308K | 0.21% | Not reported | New | Q4 2025 |
| BFBLFYBlue Foundry Bancorp | $185K | 0.13% | 0.10% | New | Q4 2025 |
| APAVDLAvadel Pharmaceuticals PLC | $163K | 0.11% | 0.01% | New | Q4 2025 |
| Q3 2025Reported Nov 7, 20255 positions | |||||
| VPVRNAVerona Pharma plc | $13.8M | 12.37% | 0.02% | New | Q3 2025 |
| TBTRMLTourmaline Bio, Inc. | $5.38M | 4.81% | 0.44% | New | Q3 2025 |
| PBPBBKPB Bankshares, Inc | $2.8M | 2.50% | 5.71% | New | Q3 2025 |
| CCCRDCoreCard Corp | $1.75M | 1.57% | Not reported | New | Q3 2025 |
| CBCFSBCFSB Bancorp, Inc. | $588K | 0.53% | 0.63% | +18.8% | Q2 2025 |
Premium opens every quarter this fund has filed